ARTL
Time to buy ARTL?Artelo Biosciences Inc.
$1.53
+$0.17 (12.87%)Prices delayed. Get real-time quotes here!
2 Days. Real Options Skills.
Join options trader Ben Sturgill as he reveals his most reliable options strategies - live. Seats are limited.
Save your seatTrader's Perspective
ARTL faded from about $19.91 on March 27, 2026 to $1.50 now after a March financing spike gave way to dilution pressure and post-split selling.
RANGE
CURRENT: $1.50
Support: $1.30 Target: $2.50
Support: $1.30Current: $1.50 Target: $2.50
BEARISH SCENARIO
A failure to hold $1.30 could see a retrace toward the $1.19 52-week low. Any new capital raise or more selling tied to warrants from the March placement would accelerate the downside.
BULLISH SCENARIO
If ARTL holds the $1.30 to $1.50 zone and volume comes back on pipeline updates, a bounce toward $2.00 to $2.50 is on the table. Resistance near $1.47 is the first hurdle, then the recent financing area around $3.20 matters.
CATALYSTS:
Analysis generated: May 28, 2026 at 12:55 PM ET
Analyst Ratings
N/A
Average Price Target: $0
Based on 0 analyst ratings in the last 3 months
Sell
0
Hold
0
Buy
0
Artelo Biosciences Inc. Earnings
We don't currently have information about Artelo Biosciences Inc.'s earnings.